Flebogamma
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $99,972 | 107 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $99,972 | 107 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, ParallelGroup Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous Human Flebogamma 5 DIF in Patients With Post-Polio Syndrome | Grifols Biologicals LLC | $99,972 | 0 |
Top Doctors Receiving Payments for Flebogamma
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Syracuse, NY | $99,972 | 107 |
Manufacturing Companies
- Grifols Biologicals LLC $99,972
Product Information
- Type Biological
- Total Payments $99,972
- Total Doctors 0
- Transactions 107
About Flebogamma
Flebogamma is a biological associated with $99,972 in payments to 0 healthcare providers, recorded across 107 transactions in the CMS Open Payments database. The primary manufacturer is Grifols Biologicals LLC.
Payment data is available from 2021 to 2021. In 2021, $99,972 was paid across 107 transactions to 0 doctors.
The most common payment nature for Flebogamma is "Unspecified" ($99,972, 100.0% of total).
Flebogamma is associated with 1 research study, including "A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, ParallelGroup Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous Human Flebogamma 5 DIF in Patients With Post-Polio Syndrome" ($99,972).